X4 Pharmaceuticals Inc. (XFOR)
undefined
undefined%
At close: undefined
0.66
4.61%
After-hours Dec 13, 2024, 07:09 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
Net Income -101.17M -93.87M -88.70M -62.13M -52.81M -43.02M -33.88M -22.98M -13.22M
Depreciation & Amortization 419.00K 513.00K 499.00K 351.00K 103.00K 155.00K 195.00K 285.00K 389.00K
Stock-Based Compensation 8.69M 5.20M 6.18M 5.43M 2.05M 5.62M 906.00K 644.00K 126.00K
Other Working Capital -890.00K 2.31M -2.66M -5.09M -484.00K -3.12M 3.24M -1.78M 1.37M
Other Non-Cash Items -4.79M 5.32M 19.29M 7.38M 7.99M 804.00K 1.75M 2.32M 441.00K
Deferred Income Tax - - -6.68M -5.78M -2.15M - -269.00K -1.39M -1K
Change in Working Capital 344.00K 5.74M -1.50M -4.06M -3.24M -4.46M 3.42M -517.00K 1.45M
Operating Cash Flow -96.51M -77.10M -70.91M -58.82M -48.05M -40.90M -27.87M -21.64M -10.82M
Capital Expenditures -60.00K -103.00K -615.00K -1.36M -174.00K -34.00K -42.00K -73.00K -170.00K
Acquisitions - - - - 26.41M - - - -
Purchase of Investments -16.82M -4.80M - - - - - -65.00K -77.00K
Sales Maturities Of Investments 2.00M - - - - - - - -
Other Investing Acitivies - 4.80M - - 1.00M - 76.00K -65.00K -77.00K
Investing Cash Flow -14.88M -103.00K -615.00K -1.36M 27.23M -34.00K 34.00K -138.00K -247.00K
Debt Repayment 20.44M -795.00K - 12.39M 481.00K 2.40M 3.28M 12.76M 4.50M
Common Stock Repurchased - - -2.00M - - -1.13M -197.00K -87.00K -12.00K
Dividend Paid - - - - - - - - -
Other Financial Acitivies 8.08M -4.61M 260.00K 283.00K 792.00K 4.47M 31.98M 5.38M 7.00M
Financial Cash Flow 88.52M 117.23M 74.25M 12.39M 140.66M -4.53M 101.26M 18.15M 11.51M
Net Cash Flow -22.78M 39.92M 2.41M -47.38M 119.59M -45.75M 73.76M -3.72M 320.00K
Free Cash Flow -96.57M -77.20M -71.52M -60.18M -48.23M -40.94M -27.91M -21.71M -10.99M